VivoSim Labs, INC.: Executive or director change
VivoSim Labs stockholders approved all proposals at the 2026 annual meeting, including an equity plan expansion, a potential reverse stock split, and warrant terms.
Neutral newsWhat happened
- Stockholders approved increasing the shares reserved under the 2022 Equity Incentive Plan by 3,165,000 shares.
The full interpretation is in the app
Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.
Read the full interpretation